Verastem, Inc. Announces Establishment of Stock Purchase Plan by Chief Executive Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM) a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that Christoph Westphal, M.D., Ph.D., Chairman and Chief Executive Officer, has established a pre-arranged personal stock purchasing plan to acquire shares of the Company's common stock.

Back to news